Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines
Elena Netchiporouk, Jennifer Gantchev, Matthew Tsang, et al.
Oncotarget (2017) Vol. 8, Iss. 56, pp. 95981-95998
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto, Xuan Beatty, Joshua M. Lynch, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 3, pp. 428-444
Open Access | Times Cited: 248
The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review
Brandon Ramchatesingh, Amelia Martínez Villarreal, Domenico Arcuri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12622-12622
Open Access | Times Cited: 35
Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL)
Feras M. Ghazawi, Nebras Alghazawi, Michelle Le, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 52
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
Sa Rang Kim, Julia M. Lewis, Benoit M. Cyrenne, et al.
Oncotarget (2018) Vol. 9, Iss. 49, pp. 29193-29207
Open Access | Times Cited: 47
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020
Małgorzata Bobrowicz, Christina Fassnacht, Desislava Ignatova, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 10, pp. 733-745
Open Access | Times Cited: 42
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
Maria Gluud, Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1229-1229
Open Access | Times Cited: 37
Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma
Edda Blümel, Andreas Willerslev-Olsen, Maria Gluud, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. e1641387-e1641387
Open Access | Times Cited: 36
XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways
Nitin Chakravarti, Amy Boles, Rachel Burzinski, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway
Marta Banchi, Maria Christina Cox, Arianna Bandini, et al.
Investigational New Drugs (2025)
Closed Access
Staphylococcus aureus alpha-toxin inhibits CD8 + T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
Edda Blümel, Shamaila Munir Ahmad, Claudia Nastasi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Helen Ray-Jones, Kate Duffus, Amanda McGovern, et al.
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 25
A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL)
Matthew Tsang, Jennifer Gantchev, Elena Netchiporouk, et al.
Oncotarget (2018) Vol. 9, Iss. 102, pp. 37647-37661
Open Access | Times Cited: 24
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Tabea C. Froehlich, Karin Müller‐Decker, Jana D. Braun, et al.
Blood (2019) Vol. 134, Iss. 5, pp. 445-455
Open Access | Times Cited: 21
The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL)
Jennifer Gantchev, Amelia Martínez Villarreal, Pingxing Xie, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 20
The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis
Jennifer Gantchev, Amelia Martínez Villarreal, Scott R. Gunn, et al.
Cell Cycle (2020) Vol. 19, Iss. 8, pp. 837-854
Open Access | Times Cited: 20
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Leukemia (2020) Vol. 35, Iss. 6, pp. 1696-1709
Open Access | Times Cited: 20
PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma
Fengjie Liu, Yumei Gao, Bufang Xu, et al.
Blood (2021) Vol. 139, Iss. 4, pp. 554-571
Open Access | Times Cited: 16
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma
Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 11
New JAK3-INSL3 Fusion Transcript—An Oncogenic Event in Cutaneous T-Cell Lymphoma
Loka Reddy Velatooru, Cheng Hu, Pedram Bijani, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2381-2381
Open Access | Times Cited: 6
The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Yukio Tonozuka, Hiroshi Tanaka, Kazumi Nomura, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 2, pp. 137-149
Open Access | Times Cited: 5
Mycosis fungoides‐derived exosomes promote cell motility and are enriched with microRNA‐155 and microRNA‐1246, and their plasma‐cell‐free expression may serve as a potential biomarker for disease burden
Lilach Moyal, Coral Arkin, Batia Gorovitz-Haris, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 5, pp. 999-1012
Open Access | Times Cited: 12
Single-Cell Heterogeneity of Cutaneous T-Cell Lymphomas Revealed Using RNA-Seq Technologies
Karolina Rassek, Katarzyna Iżykowska
Cancers (2020) Vol. 12, Iss. 8, pp. 2129-2129
Open Access | Times Cited: 12
Are we there yet? cellular therapies for cutaneous T cell lymphoma
Pınar Ataca Atilla, Erden Atilla
Current Research in Translational Medicine (2023) Vol. 71, Iss. 2, pp. 103390-103390
Closed Access | Times Cited: 4
From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation
Emily R. Gordon, Lauren M Fahmy, Megan H. Trager, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 9, pp. 1954-1962
Closed Access | Times Cited: 1
Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro
Catalina Silva‐Hirschberg, Hannah Hartman, Samantha Stack, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top